Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
78.71
-2.48 (-3.05%)
Aug 7, 2025, 4:00 PM - Market closed
MorphoSys AG Market Cap
Soleno Therapeutics has a market cap or net worth of $4.16 billion as of August 8, 2025. Its market cap has increased by 171.24% in one year.
Market Cap
4.16B
Enterprise Value
3.91B
1-Year Change
171.24%
Ranking
Category
Stock Price
$78.71
Market Cap Chart
Since November 13, 2014, Soleno Therapeutics's market cap has increased from $24.70M to $4.16B, an increase of 16,722.27%. That is a compound annual growth rate of 61.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 4.09B | 111.11% |
| Dec 31, 2024 | 1.94B | 57.88% |
| Dec 29, 2023 | 1.23B | 7,477.78% |
| Dec 30, 2022 | 16.20M | -50.46% |
| Dec 31, 2021 | 32.70M | -78.72% |
| Dec 31, 2020 | 153.70M | 17.06% |
| Dec 31, 2019 | 131.30M | 257.77% |
| Dec 31, 2018 | 36.70M | 103.89% |
| Dec 29, 2017 | 18.00M | 40.63% |
| Dec 30, 2016 | 12.80M | -44.10% |
| Dec 31, 2015 | 22.90M | 126.73% |
| Dec 31, 2014 | 10.10M | -59.11% |
| Nov 13, 2014 | 24.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 573.91B |
| Johnson & Johnson | 410.14B |
| AbbVie | 347.78B |
| AstraZeneca | 228.71B |
| Abbott Laboratories | 228.33B |
| Novartis AG | 221.76B |
| UnitedHealth Group | 219.07B |
| Novo Nordisk | 200.63B |